Invitae is a company within the Biotechnology / Healthcare category. Invitae is a medical genetics company that provides comprehensive genetic testing and interpretation services. It focuses on oncology, reproductive health, and rare disease diagnostics with the goal of making genetic information accessible at scale. Following a 2024 bankruptcy filing, its assets were acquired by LabCorp.
Invitae was founded in 2010 and is headquartered in San Francisco, CA.
Invitae is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for Invitae is Moderate. Significant factual deltas detected.
AI models classify Invitae as a Challenger. AI names competitors first.
Invitae appeared in 6 of 8 sampled buyer-intent queries (75%). Invitae has strong brand recognition but often gets buried under its acquirer (LabCorp) or larger competitors like Myriad in generic category searches unless 'low cost' or specific test names are mentioned.
AI reliably describes Invitae as a major genetic testing provider characterized by high-volume, lower-cost sequencing. However, descriptions often lag behind the company's 2024 bankruptcy and subsequent acquisition by LabCorp, leading to outdated depictions of its financial health and independence. Key gap: The most significant gap is the distinction between Invitae as an independent public company (NVTA) and its current status as an acquired asset of LabCorp following bankruptcy. AI often defaults to describing it as an active, independent entity.
Of 5 key facts verified about Invitae, 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Current operational status and corporate structure following the 2024 asset sale to LabCorp.
Buyers turn to Invitae for In-house Hospital Labs: Hospitals often use internal genetics departments or academic medical centers for testing and interpretation., Genetic Counseling AgenciesCare Management: Specialized genetic counseling firms that manage the testing process via various third-party labs for patients., among 2 documented problem areas.
Buyers evaluating Invitae typically ask AI models about "hereditary cancer genetic testing companies", "affordable whole genome sequencing for patients", "best carrier screening for pregnancy 2024", and 3 similar queries.
Invitae's main competitors are Color Health, Labcorp, Myriad Genetics, Inc.. According to AI models, these are the brands most frequently named alongside Invitae in buyer-intent queries.
Invitae's core products are Hereditary Cancer Panels, Reproductive Health (NIPS/Carrier) Testing, Rare Disease Diagnostics, Pharmacogenomics Panels..
Invitae uses Insurance-based, Patient-Pay (Fixed-price), and Institutional Billing..
Invitae serves Physicians, Health Systems, Genetic Counselors, and Patients..
Invitae A mission-driven focus on reducing the cost of genetic testing to democratize access to genomic data for all patients.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/invitae
Last analyzed: April 10, 2026
Founded: 2010
Headquarters: San Francisco, California, USA